Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Photocure to present at the DNB Nordic Healthcare Conference in Oslo

Oslo, Norway, December 6, 2019 - Photocure ASA (OSE: PHO) will be presenting at the DNB Nordic Healthcare Conference in Oslo on December 12.The presentation is scheduled at 10:30 am CET at the DNB head office in Oslo and will be held by Dan Schneider, President and CEO of Photocure ASA. The presentation will be posted on www.photocure.com when held on December 12. Company contact:Erik DahlChief Financial OfficerTel: +47 450 55 000Email: ed@photocure.com About Photocure ASAPhotocure, The Bladder Cancer Company, delivers transformative solutions to improve the lives of

Biovica strengthens management team

Biovica, active in cancer diagnostics, today announced that Henrik Winther was appointed SVP Business Development and will be part of the management team. He most recently comes from the role of SVP Precision Diagnostics at Immunovia.“Henrik possesses a rare combination of scientific expertise and commercial experience. With his many years of diagnostics background, he brings with him tremendous insight and an extensive network of contacts. Henrik is an important piece of the puzzle in Biovica's continued market expansion,” said Anders Rylander, CEO of Biovica. Winther has previously

Camurus has completed a directed share issue of approximately 3.7 million shares, raising proceeds of approximately 300 MSEK

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, JAPAN, AUSTRALIA, SOUTH AFRICA, NEW ZEALAND, HONG KONG, SINGAPORE OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OF THIS PRESS RELEASE WOULD BE UNLAWFUL   Lund, Sweden — 6 December 2019 — Camurus AB (publ) (“Camurus” or the “Company”) (Nasdaq Stockholm, CAMX) has completed a directed share issue of approximately 300 MSEK. The board of directors of Camurus has, based on the authorization granted by the annual general meeting on 9 May 2019, resolved on a directed share

Nimo-KG launches new belt lift: "Great hygiene benefits for the food industry"

Better hygiene and easier maintenance. These are some of the benefits of Nimo-KG's new belt-driven lift. The company from Skåne, Sweden, designed the lift following requests from companies in several different industries and countries, including a major German manufacturer of process equipment for the food industry.“So far, we've sold the new lift to companies that produce salads and charcuterie, but it's suitable for all kinds of production in the food industry, and the lift's hygiene aspects are of particular benefit," says Martin Olsson, MD at Nimo-KG. Martin Olsson, MD at Nimo-

Ascelia Pharma appoints Julie Waras Brogren as Chief Commercial Officer

Ascelia Pharma AB (publ) (ticker: ACE) today announced that Julie Waras Brogren has been appointed as Chief Commercial Officer (CCO) of Ascelia Pharma. Julie will be a member of the Executive Management and will start in the beginning of January 2020.The appointment of Julie Waras Brogren as CCO marks an important step for Ascelia Pharma as the company is approaching commercial stage. With more than 18 years of extensive leadership experience in global product launches, market access and life cycle management from senior roles in the biopharma and medtech industries, Julie brings in-depth

Exercise of the overallotment option in K-Fastigheter and end of stabilisation period

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONGKONG, JAPAN, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA, THE UNITED STATES OF AMERICA OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THE PRESS RELEASE.Carnegie Investment Bank AB (publ) (“Carnegie”) and Danske Bank A/S, Danmark, Sverige Filial (“Danske Bank” and together with Carnegie, “Joint Bookrunners”) exercise the overallotment option of 1,125,000

Xspray Pharma has carried out a directed share issue raising gross proceeds of approximately SEK 122 million

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL PURSUANT TO APPLICABLE RULES OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES. Solna, 5 December 2019 Xspray Pharma AB (publ) (“Xspray” or the “Company”) has, based on the authorisation given by Xspray’s annual general meeting on 23 May 2019, and in accordance with what the Company indicated in a press release on 5 December 2019, successfully carried out a

Hoist Finance successfully completes the first-ever Italian investment grade rated securitisation backed by a portfolio comprising only unsecured NPLs

Hoist Finance has successfully completed the securitisation of a portfolio of Italian unsecured non-performing loans (“NPLs”) with a gross book value of EUR 5.0 billion (the “Transaction”) that was announced on 5 November 2019. This Transaction is a landmark representing the first-ever Italian investment grade rated securitisation backed by a portfolio comprising only unsecured NPLs. The loans were extended to both corporations and individuals, representing 42.6% and 57.4% of the asset pool by gross book value, respectively. The Transaction involves the issuance of EUR 337m notes

BAKKAFROST – Preliminary results of the Subsequent Offering

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, WHETHER IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG, KONG, JAPAN, THE UNITED STATES, SWITZERLAND OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN.Reference is made to the announcement from P/F Bakkafrost ("Bakkafrost") on 20 November 2019 of a subsequent offering of up to 1,000,000 new shares in Bakkafrost at a subscription price of NOK 500 per Offer Share (the "Subsequent

BioArctic’s partner Eisai presents data from the ongoing BAN2401 Phase 2b extension study in early Alzheimer’s disease

Stockholm, Sweden, December 5, 2019 – BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that data from the ongoing BAN2401 Phase 2b open-label extension study in early Alzheimer’s disease patients was presented by Eisai at the Clinical Trials in Alzheimer’s Disease (CTAD) conference in San Diego, US. A subset of patients from the core Phase 2b study enrolled in the open label extension study. The analysis compared baseline assessments from the open-label extension phase with results at the end of the core Phase 2b study. Patients were off treatment between the end of the core

Update regarding Fastpartner’s offer of D-shares

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, HONG KONG, CANADA, NEW ZEELAND, JAPAN, SWITZERLAND, OR SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURES. ADDITIONAL RESTRICTIONS ARE APPLICABLE. PLEASE SEE IMPORTANT INFORMATION AT THE END OF THE ANNOUNCEMENT.Swedbank AB (publ) has up to now received orders exceeding the base offer of up to 7,000,000 common shares of series D. The price per common share of series D in the offer is

Lundin Gold Reports Increase in Positions by Major Shareholders

VANCOUVER, BC, December 5, 2019 /CNW/ - Lundin Gold Inc. ("Lundin Gold" or the "Company") (TSX: LUG, Nasdaq Stockholm: LUG) reports that its two largest shareholders have each agreed to increase their interest in the Company through the acquisition of the Company’s common shares from Kinross Gold Corporation. A subsidiary of Newcrest Mining Limited (“Newcrest”) has agreed to acquire 10,977,502 common shares of Lundin Gold on December 5, 2019, resulting in an aggregate holding of 71,470,787 common shares. The acquisition will increase Newcrest’s interest in Lundin Gold from approximately

EXTRAORDINARY GENERAL MEETING

To the shareholders of Nustay A/S The board of directors hereby convenes an extraordinary general meeting of Nustay A/S, CVR no. 36 09 03 16, (the ”Company”), to be held on: Friday 20 December 2019 at 16:00 (CET) at Gorrissen Federspiel Advokatpartnerselskab, Axeltorv 2, DK-1609 Copenhagen V, DenmarkAgenda 1.                  Election of members to the board of directors 2.                  Authorisations to the board of directors to increase the share capital of the Company 2.a                    Authorisation to the board of directors to increase the share capital at

Camurus intends to launch a directed share issue of up to 300 MSEK

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, JAPAN, AUSTRALIA, SOUTH AFRICA, NEW ZEALAND, HONG KONG, SINGAPORE OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OF THIS PRESS RELEASE WOULD BE UNLAWFUL   Lund, Sweden — 5 December 2019 — Camurus AB (publ) (“Camurus” or the “Company”) (Nasdaq Stockholm, CAMX) today announced its intention to execute a directed share issue of up to 300 MSEK to Swedish and international institutional investors (the “Issue”). The company has retained Carnegie Investment Bank AB (publ), DNB

Xspray Pharma contemplates a directed share issue

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL PURSUANT TO APPLICABLE RULES OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES. Solna, 5 December 2019 Xspray Pharma AB (publ) (“Xspray” or the “Company”) has mandated Carnegie Investment Bank and Zonda Partners to evaluate the conditions for a directed share issue of approximately 1.5 million new shares (the “Issue”) to institutional investors through an

FISKARS CORPORATION: ACQUISITION OF OWN SHARES 05.12.2019

Fiskars Corporation  NOTIFICATION 05.12.2019 at 18:30 EET/EEST FISKARS CORPORATION: ACQUISITION OF OWN SHARES 05.12.2019 Date 05.12.2019Exchange transaction BuyShare class FSKRSAmount       1,000Average price/share 11.6550  EUR  Highest price/share 11.6800  EUR Lowest price/share 11.6200  EUR Total price  11,655.00 EUR  The shares held by Fiskars Corporation on 05.12.2019: FSKRS 395,677  On behalf of Fiskars Corporation Skandinaviska Enskilda Banken AB (Publ) Antti Salakka   Mikko

EAB GROUP PLC: ACQUISITION OF OWN SHARES 05.12.2019

EAB GROUP PLC NOTIFICATION 05.12.2019 at 18:30 EAB GROUP PLC: ACQUISITION OF OWN SHARES 05.12.2019   Date 05.12.2019  Exchange transaction Buy  Share class EAB  Amount 280  Average price/share 2.5800 EURHighest price/share 2.5800 EURLowest price/share 2.5800 EURTotal price 722.40 EUR      The shares held by EAB Group Plc on 05.12.2019:   EAB 6,455     On behalf of EAB Group Plc  Skandinaviska Enskilda Banken AB

Eva Vitell appointed HYBRIT’s new Managing Director

HYBRIT Development AB, which is owned by SSAB, LKAB and Vattenfall, appoints Eva Vitell as the new Managing Director. In her new role, Eva will drive development work during an intensive period, develop the organization and ensure the ambitious schedule for HYBRIT remains on track.Eva Vitell joins HYBRIT Development from Vattenfall Electricity Distribution, where she today is responsible for Customers and Market. ”I’m really pleased and excited. Having a chance to be involved in revolutionizing the steel industry and contribute to the transition to being fossil-free with highly skilled

Norway Royal Salmon (NRS) has been granted NOK 400 million in green financing from Danske Bank

In the first quarter of 2019, the Group's credit limit increased from NOK 1 400 million to NOK 2 000 million. It is NOK 400 million of this credit limit that is now converted to a green loan. It is gratifying to see that our commitment to sustainable production is valued by the bank and provides more favorable loan terms. Norway Royal Salmon believes that sustainable production of salmon is very important for our long-term financial value creation. We will supply high-quality nutritious salmon with the help of safe and committed employees while ensuring minimal environmental impact.

Repurchase of shares in Nobina

During the period 28 November - 4 December 2019, Nobina AB (publ) (“Nobina”) repurchased a total of 182,461 Nobina shares within the framework of the repurchase programme introduced by the Board of Directors to meet the requirements arising under Nobina’s Share Saving Scheme, meaning securing the delivery of Performance Shares to the participants and securing and covering the costs for any social security contributions that may arise. The repurchase programme, which Nobina announced on 29 October 2019, is being implemented in accordance with the Market Abuse Regulation (EU) No 596/2014 (“MAR”)

Changes in Eltel’s Group Management Team

Saila Miettinen-Lähde has been appointed new Chief Financial Officer (CFO) of Eltel and joins the Group Management Team. Saila assumes her position as of 1 March 2020.Saila is a proven leader with broad experience from various top management positions in public companies. Most recently she held the position as Chief Executive Officer, CEO, of Endomines AB. Prior to that, she was working as CFO for F-Secure as well as Deputy CEO and CFO of Talvivaara Mining Company. Saila holds a Master of Science degree in engineering from the Tampere University of Technology. Saila replaces Petter

#19-1153 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details see attached file. For further information concerning this NGM notice please contact: Listing on +46 8 566 390 20 or at listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for

Power production in November 26.3 GWh

Weeker winds than normal in November resulted in a power production of 26.3 GWh, compared to the month’s budget of 32.3 GWh. Halmstad 5 December, 2019 ARISE AB (publ) For further information, please contact Daniel Johansson, CEO Arise AB, +46 702 244 133 This information is information that Arise AB is obliged to make public pursuant to the EU MarketAbuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 16.25 CET on 5 December, 2019.  Regarding information about how we process your personal data we refer

Change in Cevial Capital Partners’ share of holding in TietoEVRY

TietoEVRY Corporation        STOCK EXCHANGE RELEASE        5 December 2019 5.00 pm EET TietoEVRY Corporation has received a notification in accordance with Chapter 9, Section 5 of the Finnish Securities Markets Act from Cevial Capital Partners Ltd. The holding of Cevial Capital Partners Ltd has fallen below the 10% threshold as a consequence of the increase in the number of shares in connection with the merger of EVRY into Tieto. On 5 December 2019, the holding of Cevial Capital Partners Ltd amounts to 11 004 295 shares, corresponding to a holding of 9.3% in TietoEVRY shares and

There are no items matching the current filter
There are no more items matching the current filter
Back to top